J.P. Morgan Private Wealth Advisors’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $142K | Buy |
31,294
+11,543
| +58% | +$52.5K | ﹤0.01% | 1663 |
|
|
2023
Q2 | $139K | Sell |
19,751
-1,233
| -6% | -$8.68K | ﹤0.01% | 1425 |
|
|
2023
Q1 | $128K | Sell |
20,984
-2,208
| -10% | -$13.5K | ﹤0.01% | 1885 |
|
|
2022
Q4 | $148K | Buy |
23,192
+4,410
| +23% | +$28.2K | ﹤0.01% | 1858 |
|
|
2022
Q3 | $180K | Buy |
18,782
+458
| +2% | +$4.39K | ﹤0.01% | 1827 |
|
|
2022
Q2 | $202K | Buy |
18,324
+4,856
| +36% | +$53.5K | ﹤0.01% | 1824 |
|
|
2022
Q1 | $224K | Buy |
13,468
+369
| +3% | +$6.14K | ﹤0.01% | 1869 |
|
|
2021
Q4 | $250K | Sell |
13,099
-3,501
| -21% | -$66.8K | ﹤0.01% | 1825 |
|
|
2021
Q3 | $409K | Sell |
16,600
-79
| -0.5% | -$1.95K | ﹤0.01% | 1582 |
|
|
2021
Q2 | $434K | Buy |
16,679
+4,111
| +33% | +$107K | ﹤0.01% | 1534 |
|
|
2021
Q1 | $398K | Buy |
12,568
+136
| +1% | +$4.31K | ﹤0.01% | 1414 |
|
|
2020
Q4 | $577K | Sell |
12,432
-3,602
| -22% | -$167K | ﹤0.01% | 1235 |
|
|
2020
Q3 | $528K | Buy |
16,034
+138
| +0.9% | +$4.54K | ﹤0.01% | 1125 |
|
|
2020
Q2 | $436K | Buy |
15,896
+5,784
| +57% | +$159K | ﹤0.01% | 1161 |
|
|
2020
Q1 | $303K | Buy |
+10,112
| New | +$303K | ﹤0.01% | 1134 |
|